155 related articles for article (PubMed ID: 11309276)
1. Cytosine-phosphoguanine methylation of estrogen receptors in endometrial cancer.
Sasaki M; Kotcherguina L; Dharia A; Fujimoto S; Dahiya R
Cancer Res; 2001 Apr; 61(8):3262-6. PubMed ID: 11309276
[TBL] [Abstract][Full Text] [Related]
2. Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer.
Sasaki M; Dharia A; Oh BR; Tanaka Y; Fujimoto S; Dahiya R
Cancer Res; 2001 Jan; 61(1):97-102. PubMed ID: 11196205
[TBL] [Abstract][Full Text] [Related]
3. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.
Sasaki M; Kaneuchi M; Sakuragi N; Dahiya R
Cancer Res; 2003 Jun; 63(12):3101-6. PubMed ID: 12810635
[TBL] [Abstract][Full Text] [Related]
4. Methylation analysis of the promoter F of estrogen receptor alpha gene: effects on the level of transcription on human osteoblastic cells.
Penolazzi L; Lambertini E; Giordano S; Sollazzo V; Traina G; del Senno L; Piva R
J Steroid Biochem Mol Biol; 2004 Jun; 91(1-2):1-9. PubMed ID: 15261302
[TBL] [Abstract][Full Text] [Related]
5. CpG methylation of the ERalpha and ERbeta genes in breast cancer.
Kim SJ; Kim TW; Lee SY; Park SJ; Kim HS; Chung KW; Lee ES; Kang HS
Int J Mol Med; 2004 Aug; 14(2):289-93. PubMed ID: 15254780
[TBL] [Abstract][Full Text] [Related]
6. Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer.
Sasaki M; Tanaka Y; Perinchery G; Dharia A; Kotcherguina I; Fujimoto Si; Dahiya R
J Natl Cancer Inst; 2002 Mar; 94(5):384-90. PubMed ID: 11880477
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of estrogen receptor by the methylation of the estrogen receptor gene in endometrial carcinoma.
Shiozawa T; Itoh K; Horiuchi A; Konishi I; Fujii S; Nikaido T
Anticancer Res; 2002; 22(1A):139-43. PubMed ID: 12017277
[TBL] [Abstract][Full Text] [Related]
8. Discovery of epigenetically masked tumor suppressor genes in endometrial cancer.
Takai N; Kawamata N; Walsh CS; Gery S; Desmond JC; Whittaker S; Said JW; Popoviciu LM; Jones PA; Miyakawa I; Koeffler HP
Mol Cancer Res; 2005 May; 3(5):261-9. PubMed ID: 15886297
[TBL] [Abstract][Full Text] [Related]
9. Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation.
Zhao C; Lam EW; Sunters A; Enmark E; De Bella MT; Coombes RC; Gustafsson JA; Dahlman-Wright K
Oncogene; 2003 Oct; 22(48):7600-6. PubMed ID: 14576822
[TBL] [Abstract][Full Text] [Related]
10. Promoter CpG methylation of oestrogen receptors in leukaemia.
Yao J; Huang Q; Zhang XB; Fu WL
Biosci Rep; 2009 Aug; 29(4):211-6. PubMed ID: 18808365
[TBL] [Abstract][Full Text] [Related]
11. Frequent methylation of estrogen receptor in prostate cancer: correlation with tumor progression.
Li LC; Chui R; Nakajima K; Oh BR; Au HC; Dahiya R
Cancer Res; 2000 Feb; 60(3):702-6. PubMed ID: 10676656
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation can selectively silence multiple promoters of steroid receptors in cancers.
Sasaki M; Kaneuchi M; Fujimoto S; Tanaka Y; Dahiya R
Mol Cell Endocrinol; 2003 Apr; 202(1-2):201-7. PubMed ID: 12770752
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ERbeta.
Monroe DG; Getz BJ; Johnsen SA; Riggs BL; Khosla S; Spelsberg TC
J Cell Biochem; 2003 Oct; 90(2):315-26. PubMed ID: 14505348
[TBL] [Abstract][Full Text] [Related]
14. Loss of estrogen receptor-alpha expression is associated with hypermethylation near its ATG start codon in gastric cancer cell lines.
Woo IS; Park MJ; Choi SW; Kim SJ; Lee MA; Kang JH; Hong YS; Lee KS
Oncol Rep; 2004 Mar; 11(3):617-22. PubMed ID: 14767512
[TBL] [Abstract][Full Text] [Related]
15. Loss of estrogen receptor (ER) expression in endometrial tumors is not associated with de novo methylation of the 5' end of the ER gene.
Navari JR; Roland PY; Keh P; Salvesen HB; Akslen LA; Iversen OE; Das S; Kothari R; Howey S; Phillips B
Clin Cancer Res; 2000 Oct; 6(10):4026-32. PubMed ID: 11051252
[TBL] [Abstract][Full Text] [Related]
16. Assessment of hypermethylated DNA in two promoter regions of the estrogen receptor alpha gene in human endometrial diseases.
Hori M; Iwasaki M; Shimazaki J; Inagawa S; Itabashi M
Gynecol Oncol; 2000 Jan; 76(1):89-96. PubMed ID: 10620447
[TBL] [Abstract][Full Text] [Related]
17. [Expression of estrogen and progesterone receptor subtypes in human endometrial carcinoma tissues].
Liao QP; Wu C; Zheng H; Yu L
Zhonghua Fu Chan Ke Za Zhi; 2005 Nov; 40(11):752-5. PubMed ID: 16324249
[TBL] [Abstract][Full Text] [Related]
18. Expression and methylation status of 14-3-3 sigma gene can characterize the different histological features of ovarian cancer.
Kaneuchi M; Sasaki M; Tanaka Y; Shiina H; Verma M; Ebina Y; Nomura E; Yamamoto R; Sakuragi N; Dahiya R
Biochem Biophys Res Commun; 2004 Apr; 316(4):1156-62. PubMed ID: 15044106
[TBL] [Abstract][Full Text] [Related]
19. Expression of uteroglobin and matrix metalloproteinase-9 genes in endometrial cancer: relationship to estrogen and progesterone receptor status.
Cioppi F; Simi L; Luciani P; Petraglia F; Susini T; Cobellis L; Serio M; Maggi M; Peri A
Oncol Rep; 2004 Feb; 11(2):427-33. PubMed ID: 14719079
[TBL] [Abstract][Full Text] [Related]
20. Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors.
Lapidus RG; Ferguson AT; Ottaviano YL; Parl FF; Smith HS; Weitzman SA; Baylin SB; Issa JP; Davidson NE
Clin Cancer Res; 1996 May; 2(5):805-10. PubMed ID: 9816234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]